Dynamic Technology Lab’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Dynamic Technology Lab’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-25,820	Closed	-$69K	–	1498
2023 Q1	$69K	Buy	25,820 +9,529	+58%	+$45.8K	0.01%	993
2022 Q4	$88K	Buy	16,291 +1,390	+9%	+$11.6K	0.01%	1004
2022 Q3	$186K	Buy	+14,901	New	+$170K	0.02%	972
2022 Q2	–	Sell	-24,187	Closed	-$184K	–	1625
2022 Q1	$184K	Buy	+24,187	New	+$229K	0.02%	953
2021 Q1	–	Sell	-13,319	Closed	-$240K	–	1555
2020 Q4	$240K	Sell	13,319 -6,766	-34%	-$101K	0.04%	762
2020 Q3	$232K	Buy	20,085 +11,075	+123%	+$183K	0.04%	761
2020 Q2	$219K	Buy	+9,010	New	+$149K	0.03%	778
2019 Q2	–	Sell	-13,488	Closed	-$224K	–	1358
2019 Q1	$224K	Buy	+13,488	New	+$256K	0.04%	787
2018 Q4	–	Sell	-5,230	Closed	-$274K	–	1383
2018 Q3	$274K	Buy	+5,230	New	+$285K	0.04%	780

Other funds holding GTHX

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dynamic Technology Lab's GTHX Position: Q2 2023 in Review

Dynamic Technology Lab sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2023, closing a stake of 25,820 shares — an estimated $69K sold.

Dynamic Technology Lab first reported a position in GTHX in Q3 2018 and held it in 9 quarters. The position peaked at $274K in Q3 2018. 80 funds tracked by Wall St. Rank hold GTHX as of Q2 2023.

Dynamic Technology Lab reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Dynamic Technology Lab sold 25,820 G1 Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $69K.
Dynamic Technology Lab first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2018 and held it in 9 quarters.
Dynamic Technology Lab's G1 Therapeutics, Inc. Common Stock position peaked at $274K in Q3 2018.
80 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Dynamic Technology Lab's 13F filing for Q2 2023, filed 14 Aug 2023.